Skip to content
OpenCapital
Get started

PAVmed Inc. PAVM Q4 2024 Annual earnings

Reported March 25, 2025 · Before market open

Revenue$10.0KMiss by $11.0KDiluted EPS-$0.06Beat by $0.34
Revenue estimate$21.0K
EPS estimate-$0.40

Next report

Aug 13, 2026 (in a month)
Revenue estimate$48.0K
EPS estimate-$0.63

Versus estimates

Revenue

Q1 2026$22.0KMiss by $52.0KQ4 2025$52.0KBeat by $27.0KQ3 2025$5.0KMiss by $7.5KQ2 2025$6.0KMiss by $4.0KQ1 2025$8.0KMiss by $2.0K
Q4 2024$10.0KMiss by $11.0K

Diluted EPS

Q1 2026-$1.17Miss by $0.48Q4 2025-$2.05Beat by $2.45Q3 2025-$8.41Miss by $2.40Q2 2025-$0.05Beat by $0.20Q1 2025-$0.07Beat by $0.22
Q4 2024-$0.06Beat by $0.34

Ask the moment PAVmed Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PAVmed Inc. report Q4 2024 earnings?
PAVmed Inc. (PAVM) reported Q4 2024 earnings on March 25, 2025 before market open.
What were PAVmed Inc.'s Q4 2024 revenue and EPS?
PAVmed Inc. reported revenue of $10.0K and diluted EPS of $-0.06 for Q4 2024.
Did PAVmed Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $21.0K by $11.0K. EPS beat the consensus estimate of $-0.40 by $0.34.
Where can I find PAVmed Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-000364) directly on SEC EDGAR. The filing index links above go to sec.gov.